Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 8/2017

01-08-2017 | Case Report

Bilateral chorea–ballism and diabetic ketoacidosis as the initial presentation of a case with maternally inherited diabetes and deafness

Authors: Tzu-Hsiang Ko, Hsun-Hua Lee, An-Tsz Hsieh, Chaur-Jong Hu, Chih-Chung Chen

Published in: Acta Diabetologica | Issue 8/2017

Login to get access

Excerpt

Maternally Inherited Diabetes and Deafness (MIDD) is a rare diabetic syndrome mainly caused by mitochondrial A3243>G point mutation. Common clinical manifestations include diabetes mellitus (DM), deafness, short stature, ophthalmic disease, myopathy, cardiac disorders, renal disease and gastrointestinal disease. We report a case of MIDD with unusual initial presentation of bilateral chorea–ballism and diabetic ketoacidosis (DKA). …
Literature
1.
Maassen JA, Janssen GMC, Hart LM (2005) Molecular mechanisms of mitochondrial diabetes (MIDD). Ann Med 37:213–221CrossRefPubMed
2.
Murphy R, Turnbull DM, Walker M et al (2008) Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med 25:383–399CrossRefPubMed
3.
Malfatti E, Laforêt P, Jardel C et al (2013) High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation. Neurology 80:100–105CrossRefPubMed
4.
Alves C, Sampaio S, Barbosa V et al (2012) Acute chorea and type 1 diabetes mellitus: clinical and neuroimaging findings. Pediatr Diabetes 13:e30–e34CrossRefPubMed
5.
Kang J-H, Kang S-Y, Choi J-C et al (2005) Chorea triggered by hyperglycemia in a maternally inherited diabetes and deafness (MIDD) patient with the A3243G mutation of mitochondrial DNA and basal ganglia calcification. J Neurol 252:103–105CrossRefPubMed
Metadata
Title
Bilateral chorea–ballism and diabetic ketoacidosis as the initial presentation of a case with maternally inherited diabetes and deafness
Authors
Tzu-Hsiang Ko
Hsun-Hua Lee
An-Tsz Hsieh
Chaur-Jong Hu
Chih-Chung Chen
Publication date
01-08-2017
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 8/2017
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-017-0982-1

Other articles of this Issue 8/2017

Acta Diabetologica 8/2017 Go to the issue

Original Article

Lifestyle-tailored interventions for South Asians with type 2 diabetes living in high-income countries: a systematic review

Original Article

Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity

Review Article

Tailoring pharmacotherapy to specific eating behaviours in obesity: Can recommendations for personalised therapy be made from the current data?

Original Article

The affective and somatic side of depression: subtypes of depressive symptoms show diametrically opposed associations with glycemic control in people with type 1 diabetes

Case Report

A novel heterozygous deletion in the intron 8–exon 9 boundary of the glucokinase gene in a Chinese pedigree of GCK-MODY

Original Article

Genome-wide gene expression profiling reveals that CD274 is up-regulated new-onset type 1 diabetes mellitus

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits